IGC Pharma, Inc. (IGC): Net Income

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$7.12M
Year ended 2025-03-31
-$6.45M
Trailing 12 months to 2025-09-30
2011-03-31: -$20.24M2012-03-31: -$7.75M2013-03-31: -$2.25M2014-03-31: -$3.02M2015-03-31: -$4.61M2016-03-31: -$2.81M2017-03-31: -$1.87M2018-03-31: -$1.79M2019-03-31: -$4.10M2020-03-31: -$7.32M2021-03-31: -$8.81M2022-03-31: -$15.02M2023-03-31: -$11.51M2024-03-31: -$13.00M2025-03-31: -$7.12M-$7.12M
2011-03-31 Net Income (USD) 2025-03-31
Period endedNet IncomeChange YoYSource filing
2025-03-31-$7.12Mn/m2025-06-27, From 2024-04-01
2024-03-31-$13.00Mn/m2025-06-27, From 2023-04-01
2023-03-31-$11.51Mn/m2024-06-24, From 2022-04-01
2022-03-31-$15.02Mn/m2023-07-07, From 2021-04-01
2021-03-31-$8.81Mn/m2022-06-23, From 2020-04-01
2020-03-31-$7.32Mn/m2021-06-14, From 2019-04-01
2019-03-31-$4.10Mn/m2020-07-13, From 2018-04-01
2018-03-31-$1.79Mn/m2019-06-14, From 2017-04-01
2017-03-31-$1.87Mn/m2018-06-21, From 2016-04-01
2016-03-31-$2.81Mn/m2017-07-14, From 2015-04-01
2015-03-31-$4.61Mn/m2016-07-14, From 2014-04-01
2014-03-31-$3.02Mn/m2015-07-14, From 2013-04-01
2013-03-31-$2.25Mn/m2014-07-15, From 2012-04-01
2012-03-31-$7.75Mn/m2014-07-15, From 2011-04-01
2011-03-31-$20.24Mn/a2012-07-16, From 2010-04-01